Revvity (RVTY) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Sale Anita Gonzales, Vp And Cao sold 84 shares at $155.48 ($13K).
- Trade date
- Oct 1, 2026
- Disclosed to the SEC
- Oct 2, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All RVTY insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
RVTY insider transactions (Form 4)
Open-market purchases and sales. 54 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Anita GonzalesVp And Cao | Sell Plan | 847,117 held (−1%) | $155.48 | $13K | -2.0% | — |
| Sep 23SEC | Maxwell KrakowiakPlease See Remarks | Sell Plan | 1,63114,781 held (−10%) | $144.53 | $236K | +5.5% | — |
| Sep 18SEC | Tajinder S. VohraPlease See Remarks | Sell Plan | 7,3306,635 held (−52%) | $140.88 | $1.0M | +8.2% | — |
| Jul 22SEC | Anita GonzalesPresident | Sell Plan | 857,201 held (−1%) | $109.48 | $9K | +39.2% | — |
| Apr 22SEC | Anita GonzalesPresident | Sell Plan | 807,319 held (−1%) | $92.80 | $7K | +64.3% | — |
| Feb 26SEC | Miriame VictorPlease See Remarks | Sell Plan | 1,86218,122 held (−9%) | $97.13 | $181K | +56.9% | — |
| Feb 25SEC | Michelle McMurry-HeathDirector | Sell | 6004,233 held (−12%) | $97.26 | $58K | +56.7% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 12,186132,245 held (−8%) | $99.55 | $1.2M | +53.1% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 7,885124,360 held (−6%) | $100.63 | $793K | +51.5% | — |
| Feb 6SEC | Joel S. GoldbergPlease See Remarks | Sell Plan | 6,42449,540 held (−11%) | $99.47 | $639K | +53.2% | — |
| Feb 6SEC | Joel S. GoldbergPlease See Remarks | Sell Plan | 3,54445,996 held (−7%) | $100.50 | $356K | +51.7% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 3,079121,281 held (−2%) | $101.45 | $312K | +50.3% | — |
| Feb 6SEC | Joel S. GoldbergPlease See Remarks | Sell Plan | 2,21743,779 held (−5%) | $101.33 | $225K | +50.4% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 1,307144,431 held (−1%) | $99.02 | $129K | +53.9% | — |
| Feb 6SEC | Prahlad R. SinghPlease See Remarks | Sell Plan | 1,068120,213 held (−1%) | $102.52 | $109K | +48.7% | — |
| Feb 6SEC | Joel S. GoldbergPlease See Remarks | Sell Plan | 53243,247 held (−1%) | $102.52 | $55K | +48.7% | — |
| Feb 4SEC | Tajinder S. VohraPlease See Remarks | Sell Plan | 5,75610,442 held (−36%) | $104.50 | $602K | +45.9% | — |
Similar past setups: not applicable. RVTY has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with RVTY in the Research Lab
RVTY has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Revvity insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $6.0M of RVTY stock on the open market; P/E 71.9 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
RVTY insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $13K | 1 |
| Q3 2026 | — | 0 | $1.3M | 3 |
| Q2 2026 | — | 0 | $7K | 1 |
| Q1 2026 | — | 0 | $4.7M | 12 |
Valuation, profit and volume
Source: Yahoo Finance, as of Oct 8, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Revvity insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $6.0M. 16 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
RVTY earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 4, 2026 | +4.6% | Sold $9K | -0.2%S&P +1.6% | +13.2% |
| May 5, 2026 | -7.9% | Sold $7K | +14.5%S&P +2.2% | -0.7% |
| Feb 2, 2026 | -5.6% | None | -7.0%S&P -0.4% | -4.5% |
| Jan 13, 2026 | +7.4% | None | +7.3%S&P -0.7% | -13.8% |
| Oct 27, 2025 | +8.0% | None | -2.5%S&P +1.4% | +8.5% |
| Jul 28, 2025 | +1.3% | None | -8.9%S&P -0.3% | -5.5% |
| Apr 28, 2025 | +1.4% | None | +0.4%S&P +0.7% | -2.9% |
| Jan 31, 2025 | +6.7% | None | -2.5%S&P -1.2% | -9.7% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
RVTY short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Insiders at Revvity
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Prahlad R. SinghPlease See Remarks | — | $2.6M | Aug 17, 2026 | — | — |
| Tajinder S. VohraPlease See Remarks | — | $1.6M | Sep 18, 2026 | — | — |
| Joel S. GoldbergPlease See Remarks | — | $1.3M | Aug 18, 2026 | — | — |
| Maxwell KrakowiakPlease See Remarks | — | $236K | Sep 23, 2026 | — | — |
| Miriame VictorPlease See Remarks | — | $181K | Feb 26, 2026 | — | — |
| Michelle McMurry-HeathDirector | — | $58K | May 11, 2026 | — | — |
| Anita GonzalesVp And Cao | — | $30K | Oct 2, 2026 | — | — |
| Alexis P. MichasDirector | — | — | Aug 25, 2026 | — | — |
| Peter BarrettDirector | — | — | May 11, 2026 | — | — |
| Michel VounatsosDirector | — | — | May 11, 2026 | 1 of 1 | — |
| Samuel R. ChapinDirector | — | — | May 11, 2026 | — | — |
| Frank WitneyDirector | — | — | May 11, 2026 | 1 of 1 | — |
| Michael A. KlobucharDirector | — | — | May 11, 2026 | — | — |
| Sophie V. VandebroekDirector | — | — | May 11, 2026 | — | — |
| Pascale WitzDirector | — | — | May 11, 2026 | — | — |
Board links: companies that share insiders with RVTY
Directors and executives who filed Form 4s for RVTY and another company in the last 12 months.
- APHAmphenol Prahlad R. Singh Please See Remarks here · Director at APH · latest filing Aug 17, 2026
- BVSBioventus Michelle McMurry-Heath Director here · Director at BVS · latest filing May 11, 2026
- IDXXIdexx Laboratories Sophie V. Vandebroek Director here · Director at IDXX · latest filing May 11, 2026
- OFIXOrthofix Medical Alexis P. Michas Director here · 10% Owner at OFIX · latest filing Aug 25, 2026
- OIO-I Glass, Inc. Samuel R. Chapin Director here · Director at OI · latest filing May 19, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
RVTY stock: common questions
Are Revvity insiders buying RVTY stock?
No. No Revvity insider reported an open-market purchase of RVTY in the past 12 months.
Are Revvity insiders selling RVTY stock?
7 insiders reported sales worth $6.0M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RVTY's P/E ratio?
RVTY trades at about 71.9 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is RVTY's 52-week range?
Over the past year RVTY has traded between $82.21 and $165.78. It last closed at $152.44 on Nov 19, 2026.